A 34-year-old male is evaluated in the surgical intensive care unit for persistent, diffus… — USMLE Step 3

A $34$ -year-old male is evaluated in the surgical intensive care unit for persistent, diffuse bleeding from his surgical incisions and intravenous line sites. Two hours ago, he underwent an emergent exploratory laparotomy for a massive retroperitoneal hemorrhage following a high-speed motor vehicle collision. During the procedure, he received a massive transfusion protocol consisting of $12$ units of packed red blood cells, $12$ units of fresh frozen plasma, and $2$ apheresis platelet units. His core body temperature is $37.1^\circ\text{C}$ ( $98.8^\circ\text{F}$ ). Vital signs show a blood pressure of $88/54\text{ mmHg}$ and a heart rate of $118\text{/min}$ . An electrocardiogram reveals sinus tachycardia with a QTc interval of $540\text{ ms}$ .

Laboratory Test	Result	Reference Range
Hemoglobin	$8.2\text{ g/dL}$	$13.5-17.5\text{ g/dL}$
Platelet count	$115,000/\text{mm}^3$	$150,000-400,000/\text{mm}^3$
Prothrombin time (PT)	$12\text{ sec}$	$11-15\text{ sec}$
Activated partial thromboplastin time (aPTT)	$28\text{ sec}$	$25-35\text{ sec}$
Fibrinogen	$210\text{ mg/dL}$	$150-400\text{ mg/dL}$
Arterial blood gas (pH)	$7.42$	$7.35-7.45$

Which of the following molecular mechanisms is the most likely primary cause of this patient's persistent coagulopathy?

Inability of gamma-carboxyglutamate residues to anchor to phospholipid membranesCevap
B
Systemic consumption of plasma serine proteases and circulating thrombocytes
C
Unregulated proteolytic cleavage of fibrin polymers and fibrinogen
D
Impaired conformational activation of the glycoprotein IIb/IIIa receptor
E
Failure of hepatic synthesis of vitamin K-dependent coagulation factors

Cevap

Inability of gamma-carboxyglutamate residues to anchor to phospholipid membranes

The correct answer identifies the fundamental role of calcium in the coagulation cascade. The patient is experiencing citrate toxicity secondary to a massive transfusion protocol. Sodium citrate, used to prevent blood products from clotting in storage, rapidly chelates the patient's circulating ionized calcium when administered in massive volumes. This acute hypocalcemia is clinically evidenced by the patient's prolonged QTc interval and hypotension. In the coagulation cascade, calcium (historically known as Factor IV) is absolutely essential; it acts as a molecular bridge that binds the gamma-carboxyglutamate (Gla) residues of Vitamin K-dependent factors (II, VII, IX, X) to the negatively charged phosphatidylserine on the surface of activated platelets. Without this binding, the tenase and prothrombinase complexes cannot assemble, resulting in severe clinical bleeding. A high-yield point for this scenario is that in vitro laboratory tests (PT and aPTT) will appear completely normal. This occurs because the laboratory adds a standardized excess of calcium to the test tube to initiate the assay, effectively masking the patient's profound in vivo hypocalcemia.

Adım Adım Çözüm

Analyze the patient's clinical presentation and recent interventions.

The patient received a massive transfusion and is bleeding diffusely. He has hypotension and a prolonged QTc interval on his ECG.

Identifying the clinical triad of massive transfusion, coagulopathy, and QT prolongation points toward a specific metabolic complication.

Interpret the laboratory findings.

PT, aPTT, and fibrinogen are completely normal. Platelet count is mildly low but adequate for hemostasis. Acidosis and hypothermia (the other parts of the lethal triad) are absent.

Normal routine coagulation labs rule out DIC and hyperfibrinolysis, isolating the coagulopathy to a factor not measured accurately by standard in vitro assays.

Correlate the prolonged QTc interval with the massive transfusion.

Blood products contain sodium citrate as an anticoagulant. Large volumes of citrate chelate serum ionized calcium, leading to severe hypocalcemia (causing the prolonged QTc).

Understanding the pharmacology of stored blood products explains the metabolic derangement.

Link hypocalcemia to the molecular mechanism of coagulation.

Calcium (Factor IV) acts as an essential bridge, connecting the gamma-carboxyglutamate (Gla) residues of factors II, VII, IX, and X to the negatively charged phospholipid surfaces of activated platelets. Without calcium, these factors cannot assemble into active complexes.

This confirms the exact molecular failure causing the bleeding despite normal in vitro labs (which have calcium artificially added back during the assay).

Anahtar Kavram

Massive transfusion causes citrate toxicity and severe hypocalcemia. Calcium (Factor IV) is fundamentally required for the binding of gamma-carboxylated coagulation factors to phospholipid membranes, and in vivo hypocalcemia causes coagulopathy even when in vitro PT/aPTT are normal.

Tahmini Süre:2m 0s

Soru

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Konular

Bu konudan daha fazla soru